RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases-Reference-Cited by-同舟云学术

RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases

Published:2019-05-17 Issue:1 Volume:27 Page:161-175
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Patel Snahel^ORCID,Webster Joshua D.,Varfolomeev Eugene,Kwon Youngsu C.,Cheng Jason H.,Zhang Juan,Dugger Debra L.,Wickliffe Kate E.,Maltzman Allie,Sujatha-Bhaskar Swathi,Bir Kohli Pawan,Ramaswamy Sreema,Deshmukh Gauri,Liederer Bianca M.,Fong Rina,Hamilton Greg,Lupardus Patrick,Caplazi Patrick,Lee Wyne P.,van Lookeren Campagne Menno,Johnson Adam^ORCID,McKenzie Brent S.,Junttila Melissa R.,Newton Kim,Vucic Domagoj

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-019-0347-0.pdf

Reference52 articles.

1. Linkermann A, Stockwell BR, Krautwald S, Anders HJ. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat Rev Immunol. 2014;14:759–67.

2. Linkermann A, Green DR. Necroptosis. N Engl J Med. 2014;370:455–65.

3. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014;15:135–47.

4. Salvesen GS, Abrams JM. Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene. 2004;23:2774–84.

5. Newton K. RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol. 2015;25:347–53.

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting necroptosis: a promising avenue for respiratory disease treatment;Cell Communication and Signaling;2024-08-28

2. Non-canonical autophosphorylation of RIPK1 drives timely pyroptosis to control Yersinia infection;Cell Reports;2024-08

3. Discovery of 5‐(1‐benzyl‐1H‐imidazol‐4‐yl)‐1,2,4‐oxadiazole derivatives as novel RIPK1 inhibitors via structure‐based virtual screening;Drug Development Research;2024-07-18

4. Mapping where and when necroptotic cell death occurs in disease;Cell Death & Differentiation;2024-06-04

5. Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis;European Journal of Pharmacology;2024-05